| 2025-12-23 |
SDBJ5200157873 |
HIKMA PHARMACEUTICALS USA INC |
7285.0 kg |
|
MILRINONE LACTATE |
| 2025-12-23 |
SDBJ5200157876 |
HIKMA PHARMACEUTICALS USA INC |
8395.0 kg |
848041.0
|
CEFAZOLIN FOR INJECTION USP G |
| 2025-12-23 |
SDBJ5200157874 |
HIKMA PHARMACEUTICALS USA INC |
6407.0 kg |
293739.0
|
DEXMEDETOMIDINE HYDROCHLORIDE |
| 2025-12-23 |
SDBJ5200157875 |
HIKMA PHARMACEUTICALS USA INC |
5054.0 kg |
848041.0
|
CEFAZOLIN FOR INJECTION USP G |
| 2025-12-17 |
SDBJ5200157837 |
HIKMA PHARMACEUTICALS USA INC |
8706.0 kg |
291813.0
|
METOPROLOL TARTRATE INJECTION |
| 2025-12-17 |
SDBJ5200157831 |
HIKMA PHARMACEUTICALS USA INC |
6315.0 kg |
291813.0
|
METOPROLOL TARTRATE INJECTION |
| 2025-12-17 |
SDBJ5200157833 |
HIKMA PHARMACEUTICALS USA INC |
9673.0 kg |
848041.0
|
CEFAZOLIN FOR INJECTION USP G |
| 2025-12-17 |
SDBJ5200157839 |
HIKMA PHARMACEUTICALS USA INC |
9137.0 kg |
848041.0
|
CEFAZOLIN FOR INJECTION USP G |
| 2025-12-17 |
SDBJ5200157830 |
HIKMA PHARMACEUTICALS USA INC |
9552.0 kg |
848041.0
|
CEFAZOLIN FOR INJECTION USP G |
| 2025-12-17 |
SDBJ5200157834 |
HIKMA PHARMACEUTICALS USA INC |
9511.0 kg |
848041.0
|
CEFAZOLIN FOR INJECTION USP G |
| 2025-12-17 |
SDBJ5200157838 |
HIKMA PHARMACEUTICALS USA INC |
6282.0 kg |
291813.0
|
METOPROLOL TARTRATE INJECTION |
| 2025-12-17 |
SDBJ5200157842 |
HIKMA PHARMACEUTICALS USA INC |
9670.0 kg |
|
MILRINONE LACTATE |
| 2025-12-17 |
SDBJ5200157841 |
HIKMA PHARMACEUTICALS USA INC |
9814.0 kg |
|
MILRINONE LACTATE |
| 2025-12-17 |
SDBJ5200157840 |
HIKMA PHARMACEUTICALS USA INC |
9334.0 kg |
848041.0
|
CEFAZOLIN FOR INJECTION USP G |
| 2025-12-17 |
SDBJ5200157836 |
HIKMA PHARMACEUTICALS USA INC |
8907.0 kg |
848041.0
|
CEFAZOLIN FOR INJECTION USP G |
| 2025-12-12 |
SDBJ5200157783 |
HIKMA PHARMACEUTICALS USA INC |
2808.0 kg |
293739.0
|
DEXMEDETOMIDINE HYDROCHLORIDE |
| 2025-12-12 |
SDBJ5200157784 |
HIKMA PHARMACEUTICALS USA INC |
6438.0 kg |
848041.0
|
CEFEPIME FOR INJECTION |
| 2025-12-12 |
SDBJ5200157782 |
HIKMA PHARMACEUTICALS USA INC |
6407.0 kg |
293739.0
|
DEXMEDETOMIDINE HYDROCHLORIDE |
| 2025-12-08 |
SDBJ5200157713 |
HIKMA PHARMACEUTICALS USA INC |
9729.0 kg |
848041.0
|
CEFAZOLIN FOR INJECTION USP G |
| 2025-12-08 |
SDBJ5200157714 |
HIKMA PHARMACEUTICALS USA INC |
9030.0 kg |
848041.0
|
LEVETIRACETAM INJECTION MGL |
| 2025-12-08 |
SDBJ5200157724 |
HIKMA PHARMACEUTICALS USA INC |
6407.0 kg |
293739.0
|
DEXMEDETOMIDINE HYDROCHLORIDE |
| 2025-12-08 |
SDBJ5200157715 |
HIKMA PHARMACEUTICALS USA INC |
8855.0 kg |
848041.0
|
CEFAZOLIN FOR INJECTION USP G |
| 2025-12-08 |
SDBJ5200157732 |
HIKMA PHARMACEUTICALS USA INC |
6356.0 kg |
848041.0
|
ACETAMINOPHEN INJECTION MG ML |
| 2025-12-08 |
SDBJ5200157716 |
HIKMA PHARMACEUTICALS USA INC |
7395.0 kg |
848041.0
|
ETOMIDATE INJECTION USP MG M |
| 2025-12-08 |
SDBJ5200157722 |
HIKMA PHARMACEUTICALS USA INC |
6407.0 kg |
293739.0
|
DEXMEDETOMIDINE HYDROCHLORIDE |
| 2025-12-08 |
SDBJ5200157720 |
HIKMA PHARMACEUTICALS USA INC |
6026.0 kg |
282759.0
|
ROCURONIUM BROMIDE INJECTION |
| 2025-12-08 |
SDBJ5200157721 |
HIKMA PHARMACEUTICALS USA INC |
8159.0 kg |
848041.0
|
CEFAZOLIN FOR INJECTION USP G |
| 2025-12-08 |
SDBJ5200157731 |
HIKMA PHARMACEUTICALS USA INC |
6397.0 kg |
848041.0
|
ACETAMINOPHEN INJECTION MG ML |
| 2025-12-08 |
SDBJ5200157717 |
HIKMA PHARMACEUTICALS USA INC |
7569.0 kg |
293739.0
|
DEXMEDETOMIDINE HYDROCHLORIDE |
| 2025-12-08 |
SDBJ5200157723 |
HIKMA PHARMACEUTICALS USA INC |
6313.0 kg |
293739.0
|
DEXMEDETOMIDINE HYDROCHLORIDE |
| 2025-12-07 |
SDBJ5200157566 |
HIKMA PHARMACEUTICALS USA INC |
6291.0 kg |
|
MIDAZOLAM IN SODIUMCH INJ |
| 2025-12-07 |
SDBJ5200157614 |
HIKMA PHARMACEUTICALS USA INC |
3758.0 kg |
|
MIDAZOLAM IN SODIUMCH INJ |
| 2025-12-07 |
SDBJ5200157613 |
HIKMA PHARMACEUTICALS USA INC |
6245.0 kg |
|
MIDAZOLAM IN SODIUMCH INJ |
| 2025-12-07 |
SDBJ5200157615 |
HIKMA PHARMACEUTICALS USA INC |
6291.0 kg |
|
MIDAZOLAM IN SODIUMCH INJ |
| 2025-12-07 |
SDBJ5200157612 |
HIKMA PHARMACEUTICALS USA INC |
4282.0 kg |
|
MIDAZOLAM IN SODIUMCH INJ |
| 2025-12-04 |
SDBJ5200157556 |
HIKMA PHARMACEUTICALS USA INC |
5552.0 kg |
848041.0
|
GLYCOPYRROLATE INJECTION |
| 2025-11-30 |
SDBJ5200157568 |
HIKMA PHARMACEUTICALS USA INC |
7800.0 kg |
|
LIDOCAINE HYDROCHLORIDEINJECTN |
| 2025-11-30 |
SDBJ5200157572 |
HIKMA PHARMACEUTICALS USA INC |
7618.0 kg |
|
LIDOCAINE HYDROCHLORIDEINJECTN |
| 2025-11-30 |
SDBJ5200157570 |
HIKMA PHARMACEUTICALS USA INC |
7288.0 kg |
|
LIDOCAINE HYDROCHLORIDEINJECTN |
| 2025-11-30 |
SDBJ5200157569 |
HIKMA PHARMACEUTICALS USA INC |
7174.0 kg |
848041.0
|
CEFEPIME FOR INJECTION |
| 2025-11-30 |
SDBJ5200157571 |
HIKMA PHARMACEUTICALS USA INC |
9777.0 kg |
848041.0
|
BUPIVACAINE HCL INJECTION |
| 2025-11-30 |
SDBJ5200157624 |
HIKMA PHARMACEUTICALS USA INC |
9519.0 kg |
848041.0
|
CEFAZOLIN FOR INJECTION USP G |
| 2025-11-30 |
SDBJ5200157586 |
HIKMA PHARMACEUTICALS USA INC |
3220.0 kg |
|
TESTOSTERONE CYPIONATEINJECTIN |
| 2025-11-30 |
SDBJ5200157584 |
HIKMA PHARMACEUTICALS USA INC |
3397.0 kg |
|
TESTOSTERONE CYPIONATEINJECTIN |
| 2025-11-30 |
SDBJ5200157620 |
HIKMA PHARMACEUTICALS USA INC |
4221.0 kg |
282759.0
|
ROCURONIUM BROMIDE INJECTION |
| 2025-11-30 |
SDBJ5200157622 |
HIKMA PHARMACEUTICALS USA INC |
9729.0 kg |
848041.0
|
CEFAZOLIN FOR INJECTION USP G |
| 2025-11-30 |
SDBJ5200157585 |
HIKMA PHARMACEUTICALS USA INC |
3397.0 kg |
|
TESTOSTERONE CYPIONATEINJECTIN |
| 2025-11-30 |
SDBJ5200157621 |
HIKMA PHARMACEUTICALS USA INC |
10728.0 kg |
848041.0
|
BUPIVACAINE HCL INJECTION |
| 2025-11-30 |
SDBJ5200157638 |
HIKMA PHARMACEUTICALS USA INC |
3397.0 kg |
|
TESTOSTERONE CYPIONATEINJECTIN |
| 2025-11-30 |
SDBJ5200157623 |
HIKMA PHARMACEUTICALS USA INC |
8598.0 kg |
848041.0
|
CEFAZOLIN FOR INJECTION USP G |